Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 301–400 of 1,000
ROLE OF ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTOR IN ENDOTHELIAL DYSFUNCTION DURING DIABETES
Fitzgerald, S. M., Kemp‐Harper, B. K., Tare, M., & Parkington, H. C. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04216.x · Cited by 57
Morikawa, K., Matoba, T., Kubota, H., Hatanaka, M., Fujiki, T., Takahashi, S., Takeshita, A., & Shimokawa, H. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000159657.93922.cb · Cited by 57
“It is reported that various risk factors, such as diabetes mellitus, hypercholesterolemia, and hypertension, cause endothelial dysfunction, leading to atherosclerosis and microvascular disorders.(1,15,16) The effects of these risk factors on NOmediated responses have been extensively studied.”
BackgroundFocus on oxidative stress in the cardiovascular and renal systems
Wilcox, C. S., & Gutterman, D. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2004 · Cited by 57
Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases
Yang, Y., Ye, Y., Deng, Y., & Gao, L. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1360891 · Cited by 56
Muscle microvascular oxygenation in chronic heart failure: role of nitric oxide availability
Ferreira, L. F., Hageman, K. S., Hahn, S. A., Williams, J. H., Padilla, D. J., Poole, D. C., & Musch, T. I. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01598.x · Cited by 56
“…similar to those previously reported in conditions such as type I diabetes (Behnke et al. 2002b), aging (Behnke et al. 2005) and CHF (present study; Diederich et al. 2002), all of which are known to impact vascular NO availability (Drexler et al. 1992, Taddei et al. 1995, De Vriese et al. 2000).”
ResultPannirselvam, M., Ding, H., Anderson, T. J., & Triggle, C. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.086 · Cited by 56
Li-jun, W., Yu, Y., Zhang, L.-G., Wang, Y., Niu, N., Li, Q., & Guo, L.-M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.031 · Cited by 56
Antiplatelet therapy in type 2 diabetes mellitus
Angiolillo, D. J. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32807f2ad9 · Cited by 56
Leo, C., Hart, J. L., & Woodman, O. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020813 · Cited by 56
“Endothelial dysfunction, characterized by the impairment of endothelium-dependent relaxation, is recognised as a critical and initiating factor in the development of diabetes-induced vascular complications [1,2].”
BackgroundResultInsulin and adiponectin inhibit the TNFα-induced ADMA accumulation in human endothelial cells
Eid, H. M. A., Lyberg, T., Arnesen, H., & Seljeflot, I. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.008 · Cited by 55
Daskoulidou, N., Zeng, B., Berglund, L. M., Jiang, H., Chen, G.-L., Kotova, O., Bhandari, S., Ayoola, J. A. O., Griffin, S., Atkin, S. L., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1234-2 · Cited by 55
Erdei, N., Bagi, Z. A., Edes, I. F., Kaley, G., & Koller, Á. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00596.2006 · Cited by 55
“vascular complications (10, 19, 36), which may lead to dis-”
BackgroundMatsumoto, T., Kobayashi, T., & Kamata, K. (2008) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.44.41 · Cited by 55
Shemyakin, A. S., Böhm, F., Wagner, H., Efendić, S., Båvenholm, P., & Pernow, J. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000210070.47205.16 · Cited by 55
“Importantly, these conditions are linked to a dysfunctional vascular endothelium, which is an early feature in the development of cardiovascular disease.(6,7) Endothelial dysfunction is characterized by reduced availability of nitric oxide (NO), which in turn results in increased vascular tone, increased platelet acti…”
BackgroundKobayashi, T., Nogami, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.327 · Cited by 54
“Diabetes mellitus is an important risk factor for increased blood pressure and for the development of atherosclerosis (Cohen, 1995; De Vriese et al., 2000; Eckel et al., 2002).”
BackgroundMatsumoto, T., Kobayashi, T., Ishida, K., Taguchi, K., & Kamata, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00753.x · Cited by 54
“It is believed that an impaired ability to vasodilate and/or an enhanced responsiveness to vasoconstrictor agonists underlie the vascular dysfunction associated with diabetes (Kamata et al., 1989; Hattori et al., 1995; De Vriese et al., 2000; Matsumoto et al., 2003).”
BackgroundAkar, F., Pektaş, M. B., Tufan, C., Söylemez, S., Sepici, A., Ulus, A. T., Gokalp, B., Öztürk, K., & Surucu, H. S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6255-7 · Cited by 54
“Diabetes-induced endothelial dysfunction is a well known abnormality leading to cardiovascular disorders [1].”
BackgroundLiu, Y., Xie, A., Singh, A. K., Ehsan, A., Choudhary, G., Dudley, S. C., Sellke, F. W., & Feng, J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002062 · Cited by 54
Platelet activation in patients with diabetic retinopathy
Bae, S. H., Lee, J., Roh, K. H., & Kim, J. S. (2003) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2003.17.2.140 · Cited by 54
Lee, H.-Y., Youn, S.-W., Cho, H.-J., Kwon, Y.-W., Lee, S.-W., Kim, S.-J., Park, Y.-B., Oh, B.-H., & Kim, H.-S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvs283 · Cited by 50
“–4 Impaired endothelium-dependent vasodilatation has been demonstrated in patients with type 1 and type 2 diabetes,(5,6) as well as in various animal models of diabetes.(2) A deregulated, chronic forkhead transcription factor FOXO1 activation with prolonged hyperglycaemia has been reported to induce pancreatic b-cell…”
BackgroundFlores, C. A., Rojas, S., Aguayo, C. R., Parodí, J., Mann, G. E., Pearson, J. D., Casanello, P. C., & Sobrevía, L. (2003) · Circulation Research · doi:10.1161/01.res.0000048197.78764.d6 · Cited by 54
Young, E. J., Hill, M. A., Wiehler, W. B., Triggle, C. R., & Reid, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-0934-y · Cited by 53
“As responses to the endotheliumindependent dilator levcromakalim were not altered, this attenuation can be identified as an endothelial dysfunction, a well-established complication in animal models of insulin resistance and diabetes [1].”
BackgroundStrutz, J., Cvitic, S., Hackl, H., Kashofer, K., Appel, H. M., Thüringer, A., Desoyé, G., Koolwijk, P., & Hiden, U. (2018) · Clinical Science · doi:10.1042/cs20180825 · Cited by 54
Endothelial dysfunction precedes C‐fiber abnormalities in primary (AL) amyloidosis
Berghoff, M., Kathpal, M., Khan, F., Skinner, M. M., Falk, R. H., & Freeman, R. L. (2003) · Annals of Neurology · doi:10.1002/ana.10552 · Cited by 53
“ACh binds to endothelial muscarinic receptors and induces the release of vasoactive substances that include NO, vasoactive prostanoids, and endothelium-derived hyperpolarizing factor.(30,31) NO is most likely the major endothelial vasodilator in the forearm skin(17,19) and its impaired synthesis or release is most lik…”
BackgroundCosta, C., Soares, R. A., Castela, Â., Adães, S., Hastert, V., Vendeira, P., & Virag, R. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01110.x · Cited by 53
14,15-Epoxyeicosa-5(Z)-Enoic-mSI: A 14,15- and 5,6-EET Antagonist in Bovine Coronary Arteries
Gauthier, K. M., Jagadeesh, S. G., Falck, J. R., & Campbell, W. B. (2003) · Hypertension · doi:10.1161/01.hyp.0000091265.94045.c7 · Cited by 53
Flavonols in the Prevention of Diabetes-induced Vascular Dysfunction
Leo, C., & Woodman, O. L. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000180 · Cited by 52
Pereira, A. M., Fernandes, R., Crisóstomo, J., Seiça, R. M. F., & Sena, C. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14733-x · Cited by 52
“(1) Groups (W; GK) maintained with vehicle (corn oil) for 8 weeks; (2) Groups treated with sulforaphane (1 mg/Kg/day, intraperitoneal) for 8 weeks (WS; GKS); (3) Groups treated with pyridoxamine (100 mg/ Kg/day, in the drinking water as previous51) for 8 weeks (WP; GKP); (4) Groups treated with sulforaphane and pyrido…”
Decreased Nitric Oxide Synthesis in Human Endothelial Cells Cultured on Type I Collagen
González-Santiago, L., López‐Ongil, S., Rodríguez-Puyol, M., & Rodríguez-Puyol, D. (2002) · Circulation Research · doi:10.1161/01.res.0000012445.68979.9d · Cited by 52
“I, and (3) the modifications of eNOS promoter activity after modulation of ILK.”
BackgroundBus, P., Scharpfenecker, M., Wilk, P. V. D., Wolterbeek, R., Bruijn, J. A., & Baelde, H. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4322-3 · Cited by 52
“Diabetic nephropathy is characterised by damage and dysfunction of the microvasculature [1].”
BackgroundEndothelial-to-mesenchymal transition: An underappreciated mediator of diabetic complications
Wang, E., Wang, H., & Chakrabarti, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1050540 · Cited by 51
“Proc Natl Acad Sci (2000) 97(6):2626–31.”
Taguchi, K., Kobayashi, T., Takenouchi, Y., Matsumoto, T., & Kamata, K. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.001 · Cited by 51
Abdallah, H. M., El‐Bassossy, H. M., Mohamed, G. A., Halawany, A. M. E., Alshali, K. Z., & Banjar, Z. M. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1340-5 · Cited by 51
“The changes in vascular reactivity are responsible for the development of many vascular complications [6].”
BackgroundExercise intolerance in Type 2 diabetes: is there a cardiovascular contribution?
Poitras, V. J., HUDSON, R. W., & Tschakovsky, M. E. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00070.2017 · Cited by 51
“, ATP, as mentioned previously, or acetylcholine) by releasing vasodilators into the interstitium (namely NO, vasodilatory prostaglandins, and endothelium-derived hyperpolarizing factor) (24).”
BackgroundTian, X., Wong, W. T., Xu, A., Chen, Z., Lu, Y., Lm, L., Lee, V. W. Y., Lau, C., Yao, X., & Huang, Y. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01416.x · Cited by 50
“Endothelial dysfunction, a hallmark in diabetes, initiates vascular pathogenesis leading to diabetic vasculopathy (De Vriese et al., 2000), and it is closely associated with reduced bioavailability of endothelium-derived NO, which can result from the reduced NO-generating capacity or exaggerated…”
Parkar, N., Bhatt, L. K., & Addepalli, V. (2016) · Food & Function · doi:10.1039/c6fo00294c · Cited by 50
Li, X., Zhang, S., Xu, W. B., Xing, B., Lu, Q., Zhang, P., Li, H., Zhang, L., Zhang, W.-C., Chen, W., et al. (2018) · Virology · doi:10.1016/j.virol.2018.05.001 · Cited by 52
Jenny, L., Ajjan, R., King, R., Thiel, S., & Schroeder, V. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12574 · Cited by 50
Vascular dysfunction in retinopathy—An emerging role for arginase
Caldwell, R. B., Zhang, W., Romero, M. J., & Caldwell, R. W. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.025 · Cited by 50
“However, studies in animals and a recent clinical trial have found no benefit with chronic oral administration of supplemental L-arginine [22,45,65,78,85].”
BackgroundFang, S. C., Cavallari, J. M., Eisen, E. A., Chen, J.-C., Mittleman, M. A., & Christiani, D. C. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwn405 · Cited by 50
Sundell, J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00375.x · Cited by 50
Maggi, A. C., Cignarella, A., Brusadelli, A., Bolego, C., Pinna, C., & Puglisi, L. (2003) · Circulation · doi:10.1161/01.cir.0000079311.39939.94 · Cited by 50
“It was apparent that (1) the mRNA of ER was more abundant than that of ER in untreated diabetic and nondiabetic SMC and (2) both ER and ER mRNA levels were consistently greater in diabetic than in control SMC under any condition tested (Figure 5).”
Matsumoto, T., Wakabayashi, K., Kobayashi, T., & Kamata, K. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-002 · Cited by 50
Does vitamin D deficiency contribute to erectile dysfunction?
Sorenson, M. B., & Grant, W. B. (2012) · Dermato-Endocrinology · doi:10.4161/derm.20361 · Cited by 49
“Diabetes leads to CVD by causing END, a precursor to atherosclerosis, as follows:(50) High levels of glucose in the blood inhibit the production of NO.(51) This inhibition impairs vasodilation of vessels and leads to atherosclerosis(52) by promoting vasoconstriction, hypertension, vascular smooth-muscle growth, inflam…”
BackgroundInfluentialFerreira, L. F., Padilla, D. J., Williams, J. H., Hageman, K. S., Musch, T. I., & Poole, D. C. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01523.x · Cited by 49
“…ageing (Taddei et al. 1995, Woodman et al. 2002, Tanabe et al. 2003), CHF (Drexler et al. 1992, Hirai et al. 1995a,b, Varin et al. 1999), and diabetes (De Vriese et al. 2000, Bagi & Koller 2003) are all associated with a downregulation of endothelial function and/or endothelial NO production.”
BackgroundMahfouz, M. M., Zhou, S. Q., & Kummerow, F. A. (2009) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.79.4.218 · Cited by 49
“Aconsiderable body of evidence implicates oxidative stress as an important pathogenic element in endothelial dysfunction [1–3] and cell injury, which contribute to atherosclerosis [4] and other cardiovascular diseases [5].”
BackgroundFenofibrate improves vascular endothelial function and contractility in diabetic mice
Xu, N., Wang, Q., Jiang, S., Wang, Q., Hu, W., Zhou, S., Zhao, L., Xie, L., Chen, J., Wellstein, A., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.024 · Cited by 49
Srivastava, P., Badhwar, S., Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.042 · Cited by 49
Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries
Cai, Y., Manio, M. M., Leung, G., Xu, A., Tang, E. H. C., & Vanhoutte, P. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.036 · Cited by 48
Self-citationBenfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat
Balakumar, P., SHARMA, R., & SINGH, M. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.012 · Cited by 48
Serelaxin: A Novel Therapeutic for Vascular Diseases
Leo, C. H., Jelinic, M., Ng, H. H., Tare, M., & Parry, L. J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.001 · Cited by 48
Matsumoto, T., Kobayashi, T., & Kamata, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.006 · Cited by 48
Vriese, A. S. D., Verbeke, F., Schrijvers, B. F., & Lameire, N. H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00249.x · Cited by 48
“Studies of endothelium-dependent vasodilation therefore need to be conducted in clinically more relevant vasculature”
BackgroundSelf-citationYamagata, K., Miyashita, A., Matsufuji, H., & Chino, M. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.11.003 · Cited by 47
“Diabetes mellitus is associated with endothelial dysfunction characterized by compromised endothelium-dependent responses [7].”
BackgroundPernow, J., Kiss, A., Tratsiakovich, Y., & Climent, B. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13242 · Cited by 47
“Loss of the modulatory role of endothelium, known as endothelial dysfunction due to decreased nitric oxide (NO) bioavailability, is thought to be an early factor in the development of diabetic vascular diseases (De Vriese et al., 2000).”
BackgroundAkap1 Regulates Vascular Function and Endothelial Cells Behavior
Schiattarella, G. G., Cattaneo, F., Carrizzo, A., Paolillo, R., Boccella, N., Ambrosio, M., Damato, A., Pironti, G., Franzone, A., Russo, G., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10185 · Cited by 47
Takahashi, M., Ando, J., Shimada, K., Nishizaki, Y., Tani, S., Ogawa, T., Yamamoto, M., Nagao, K., Hirayama, A., Yoshimura, M., et al. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0479-4 · Cited by 46
“The duration of the disease tends to be long in diabetes patients with PMI, with severe chronic inflammation mediated by cytokines [27] accompanied with oxidative stress [28] and endothelial dysfunction [29].”
BackgroundThe role of the renal kallikrein–kinin system in diabetic nephropathy
Riad, A., Zhuo, J. L., Schultheiß, H., & Tschöpe, C. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328011a20c · Cited by 46
“[4].”
Is insulin resistance atherogenic? Possible mechanisms
DeFronzo, R. A. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.05.002 · Cited by 46
Kiss, L., & Szabó, C. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000900007 · Cited by 46
Taguchi, K., Kobayashi, T., Matsumoto, T., & Kamata, K. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01189.2010 · Cited by 44
“We and others (8, 10, 20, 21, 35) have suggested that diabetes and insulin resistance involve impaired endothelial function, a causal factor in hypertension and other cardiovascular diseases.”
BackgroundPingali, U., Sukumaran, D., & Nutalapati, C. (2020) · Phytotherapy Research · doi:10.1002/ptr.6771 · Cited by 45
“…pathway activity, glucose autoxidation, protein kinase C activation, and advanced glycation end product (AGE) formation, and these hyperglycemia-induced metabolic pathways are significantly implicated in the pathogenesis of EnD (De Vriese, Verbeuren, Van De Voorde, Lameire, & Vanhoutte, 2000).”
BackgroundGuo, Z., Zhang, Y., Liu, C., Youn, J. Y., & Cai, H. “. (2021) · Diabetes · doi:10.2337/db20-0591 · Cited by 45
Gene Therapy for Erectile Dysfunction: Fact or Fiction?
Kendirci, M., Telöken, P., Champion, H. C., Hellstrom, W. J. G., & Bivalacqua, T. J. (2006) · European Urology · doi:10.1016/j.eururo.2006.08.007 · Cited by 45
“Substantial evidence supports the involvement of ROS, in particular superoxide anion, in diabetic vascular dysfunction [87,88].”
BackgroundCsanyi, G., Leprán, I., Flesch, T., Telegdy, G., Szabó, G., & Mezei, Z. (2007) · PubMed · Cited by 45
Sharma, S. S., & Sayyed, S. G. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04481.x · Cited by 45
“Impaired endotheliumdependent vasodilatation has been demonstrated in various vascular beds of animal models of diabetes and in humans with type 1 and type 2 diabetes.(41,42) Free radicals, such as and OH, cause vascular endothelial damage and reduced NO-mediated vasodilatation.”
BackgroundMabley, J. G., & Soriano, F. G. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161054368571 · Cited by 45
Laviola, L., Orlando, M. R., Incalza, M. A., Caccioppoli, C., Melchiorre, M., Leonardini, A., Cignarelli, A., Tortosa, F., Labarbuta, R., Martemucci, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081930 · Cited by 44
“endothelial layer, thus initiating the atherosclerotic cascade [1].”
BackgroundTargeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
Tabaa, M. M. E., & Tabaa, M. M. E. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114057 · Cited by 44
Bi, W., Cai, J., Liu, S., Baudy-Floc’h, M., & Bi, L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.022 · Cited by 44
Smirnova, E. N., Podtaev, S., Mizeva, I. A., & Loran, E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113494881 · Cited by 44
Matsumoto, T., Kobayashi, T., Wachi, H., Seyama, Y., & Kamata, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.005 · Cited by 44
Goya, K., Sumitani, S., Otsuki, M., Xu, X., Yamamoto, H., Kurebayashi, S., Saito, H., Kouhara, H., & Kasayama, S. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.08.003 · Cited by 43
Resistance Exercise Restores Endothelial Function and Reduces Blood Pressure in Type 1 Diabetic Rats
Mota, M. M., da Silva, T. L. T. B., Fontes, M. T., Barreto, A. S., Araújo, J. E. D. S., de Oliveira, A. C. C., Wichi, R. B., & Santos, M. R. V. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20140087 · Cited by 43
Pacinella, G., Ciaccio, A. M., & Tuttolomondo, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247515 · Cited by 43
Kobayashi, T., Nemoto, S., Ishida, K., Taguchi, K., Matsumoto, T., & Kamata, K. (2012) · Clinical Science · doi:10.1042/cs20110621 · Cited by 43
Taguchi, K., Hida, M., Hasegawa, M., Matsumoto, T., & Kobayashi, T. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500618 · Cited by 43
Chuter, V., Quigley, F., Tosenovsky, P., Ritter, J. C., Charles, J., Cheney, J., Fitridge, R., & Australian Diabetes‐related Foot Disease Guidelines & Pathways Project (2022) · Journal of Foot and Ankle Research · doi:10.1186/s13047-022-00550-7 · Cited by 44
“PAD commonly co-exists with systemic atherosclerosis and underlying generalised endothelial dysfunction due to vascular inflammation and an abnormal metabolic state [9, 12].”
BackgroundEndothelial dysfunction in human diabetes
Mäkimattila, S., & Yki‐Järvinen, H. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0054-x · Cited by 43
High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction
Mohan, S., Konopiński, R., Yan, B., Centonze, V. E., & Natarajan, M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00575.2007 · Cited by 43
“ACCELERATED ATHEROSCLEROSIS, one of the major vascular complications of diabetes, is attributed to hyperglycemia mediatedendothelial dysfunction (6).”
BackgroundLeo, C. H., Joshi, A., & Woodman, O. L. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01197.2009 · Cited by 43
Roig-Revert, M. J., Lleó-Pérez, A., Zanón‐Moreno, V., Vivar-Llopis, B., Marín-Montiel, J., Dolz‐Marco, R., Muñoz, L. A., Albert-Fort, M., Gálvez, M. I. L., Galarreta, D., et al. (2015) · BioMed Research International · doi:10.1155/2015/408180 · Cited by 43
Shukla, N., Thompson, C. S., Angelini, G. D., Mikhailidis, D. P., & Jeremy, J. Y. (2002) · Diabetologia · doi:10.1007/s00125-002-0888-4 · Cited by 43
“Several studies have now shown a reduction of nitric oxide and an increase in O2 formation by the vasculature of diabetic laboratory animals [8, 9, 20, 21, 22, 23].”
BackgroundShen, B. Q., Chun-ling, Y., Ye, K., & Liu, J. (2003) · PubMed · Cited by 42
Vascular risk in obesity: Facts, misconceptions and the unknown
King, R., & Ajjan, R. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116675488 · Cited by 42
Sampei, S., Okada, H., Tomita, H., Takada, C., Suzuki, K., Kinoshita, T., Kobayashi, R., Fukuda, H., Kawasaki, Y., Nishio, A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.623582 · Cited by 42
Ugwoke, C. K., Cvetko, E., & Umek, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020847 · Cited by 42
Pinho, J., de Medeiros, M. A. A., Capettini, L. D. S. A., Rezende, B., Campos, P. P., Andrade, S. P., Côrtes, S. F., Cruz, J. S., & Lemos, V. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00955.x · Cited by 42
“Possible explanations for these apparent discrepancies may be related to time-dependent changes in endothelial function (Kobayashi and Kamata, 1999; Kobayashi et al., 2005), the vascular bed studied and model and severity of diabetes (De Vriese et al., 2000; Kobayashi et al., 2005).”
BackgroundDynamic Synchrotron Imaging of Diabetic Rat Coronary Microcirculation In Vivo
Jenkins, M. J., Edgley, A. J., Sonobe, T., Umetani, K., Schwenke, D. O., Fujii, Y., Brown, R. D., Kelly, D. J., Shirai, M., & Pearson, J. T. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237172 · Cited by 42
“tron radiation contrast angiography and (2) to investigate the early origins of vascular dysfunction in individual coronary microvessels using the streptozotocin-induced diabetic rat.”
BackgroundMechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery
Matsumoto, T., Yoshiyama, S., Kobayashi, T., & Kamata, K. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.001 · Cited by 42
Salheen, S. M., Panchapakesan, U., Pollock, C. A., & Woodman, O. L. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.02.003 · Cited by 42
“[1,2].”
Endothelial dysfunction and hypertension in diabetes mellitus
Dandona, P., Chaudhuri, A., & Aljada, A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.006 · Cited by 42
Tóth, E., Racz, A., Toth, J., Kaminski, P. M., Wolin, M. S., Bagi, Z. A., & Koller, Á. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01335.2006 · Cited by 42
“Also, aldose reductase and NO synthase share the same pool of NADPH, as an obligate cofactor (17).”
BackgroundInfluentialYu, Y., OHMORI, K., KONDO, I., Yao, L., NOMA, T., TSUJI, T., Mizushige, K., & KOHNO, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00513-8 · Cited by 42
Impaired Nitric Oxide Function in the Basilar Artery of the Obese Zucker Rat
Karagiannis, J., Reid, J. J., Darby, I. A., Roche, P. J., Rand, M. J., & Li, C. G. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200310000-00007 · Cited by 42
“Impaired endothelium-dependent relaxation of blood vessels has been confirmed in human type 2 diabetes; however, studies investigating insulin resistance and type 2 diabetes are scarce and have yielded conflicting results.(5) In the OZR, hyperinsulinemia and hypercholesterolemia are believed to be associated with the…”
ResultCardiovascular determinants of life span
Shi, Y., Camici, G. G., & Lüscher, T. F. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0727-2 · Cited by 41
“In addition, the unique glycation reaction in diabetes produces more pronounced oxidative free radicals through intermediate compounds that in turn increase the levels of reactive oxygen species [35, 64-71].”
BackgroundRodrigues, A. M., Bergamaschi, C. T., Fernandes, M. J. S., Paredes-Gamero, E. J., Curi, M. V., Ferreira, A. T., Araujo, S. R. R., Punaro, G. R., Maciel, F. R., Nogueira, G. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097452 · Cited by 38
“The main effect of NAC supplementation and aerobic exercise was on hyperglycemia, which is characteristic of DM, and stimulates the production of oxidative stress [26].”
BackgroundEffects of taurine on the reactivity of aortas from diabetic rats
Abebe, W. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.11.012 · Cited by 41
Ebrahimi, F., Aryaeian, N., Pahlavani, N., Abbasi, D., Hosseini, A. F., Fallah, S., Moradi, N., & Heydari, I. (2019) · PubMed Central · doi:10.22038/ajp.2019.12785 · Cited by 41
Fresta, C. G., Caruso, G., Fidilio, A., Platania, C. B. M., Musso, N., Caraci, F., Drago, F., & Bucolo, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239305 · Cited by 41
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.